TWIST1 and exocrine pancreatic carcinoma: In fact, pharmacological inactivation of the Twist1 function showed promising effects of protecting cancer-induced cachexia, with a significant survival benefit in the experimental model of pancreatic carcinoma (Parajuli et al., 2018).